Report cover image

DNA Sequencing Market Size, Share & Trends Analysis Report By Product & Service (Instruments, Consumables), By Technology (Sanger Sequencing, Next-Generation Sequencing), By Workflow, By Application, By End Use, And Segment Forecasts, 2025 - 2033

Publisher Grand View Research
Published Nov 28, 2025
Length 150 Pages
SKU # GV20649725

Description

DNA Sequencing Market Summary

The global DNA sequencing market size was estimated at USD 14.88 billion in 2024 and is projected to reach USD 91.88 billion by 2033, growing at a CAGR of 22.66% from 2025 to 2033. The market’s steady growth is driven by rising adoption of next generation sequencing technologies, increasing clinical applications in oncology and rare disease diagnostics, and expanding investments in genomics research globally.

Increasing Adoption of DNA Vaccines

The market for DNA sequencing is seeing a sharp increase in demand due to the growing use of DNA vaccines. High-precision sequencing is essential to the design, validation, and optimization of plasmid constructs encoding antigenic proteins in DNA vaccine development. To ensure proper gene insertion, confirm plasmid integrity, and identify potential mutations during the manufacturing process, sequencing is crucial.

Next-generation sequencing (NGS) is crucial for verifying the genetic stability and purity of large-scale DNA vaccine production, which also requires strict quality control and adherence to regulatory compliance. Sequencing-based workflows for preclinical validation, immunogenicity assessment, and safety profiling have become increasingly popular among developers due to the global shift toward faster vaccine development, which pandemic preparedness initiatives have accelerated.

Global DNA Sequencing Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For the purpose of this report, Grand View Research has segmented the DNA sequencing market on the basis of product & services, technology, workflow, application, end use, and region.
  • Product & Service Outlook (Revenue, USD Million, 2021 - 2033)
  • Instruments
  • Consumables
  • Services
  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Sanger Sequencing
  • Next-Generation Sequencing
  • Whole Genome Sequencing (WGS)
  • Whole Exome Sequencing (WES)
  • Targeted Sequencing & Resequencing
  • Third Generation DNA Sequencing
  • Single-Molecule Real-Time Sequencing (SMRT)
  • Nanopore Sequencing
  • Workflow Outlook (Revenue, USD Million, 2021 - 2033)
  • Pre-sequencing
  • Sequencing
  • Data Analysis
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Oncology
  • Reproductive Health
  • Clinical Investigation
  • Agrigenomics & Forensics
  • HLA Typing/Immune System Monitoring
  • Metagenomics, Epidemiology & Drug Development
  • Consumer Genomics
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Academic Research
  • Clinical Research
  • Hospitals & Clinics
  • Pharmaceutical & Biotechnology Companies
  • Other Users
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
  • Latin America
  • Brazil
  • Argentina
  • MEA
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
Please note The report will be delivered in 2-3 business days upon order notification.

Table of Contents

150 Pages
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Segment Definitions
1.1.1.1. Product & Service Segment
1.1.1.2. Technology Segment
1.1.1.3. Workflow Segment
1.1.1.4. Application
1.1.1.5. End Use
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Objective
1.4.1. Objective 1
1.4.2. Objective2
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. GVR’s Internal Database
1.6.3. Secondary Sources
1.6.4. Primary Research
1.7. Information or Data Analysis:
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.9.2. List of Secondary Sources
1.9.3. List of Abbreviations
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables and Trends
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Derivers
3.3.1. Increasing adoption of DNA vaccines
3.3.2. Declining cost of genome sequencing
3.4. Market Restraint Analysis
3.4.1. Regulatory and quality compliance challenges
3.5. Business Environment Analysis
3.5.1. PESTEL Analysis
3.5.2. Porter’s Five Forces Analysis
Chapter 4. DNA Sequencing Market: Product & Service Estimates & Trend Analysis
4.1. Product & Service Segment Dashboard
4.2. Global DNA Sequencing Market: Product & Service Movement Analysis
4.3. Consumables
4.3.1. Consumables, 2021 - 2033 (USD Million)
4.4. Instruments
4.4.1. Instruments, 2021 - 2033 (USD Million)
4.5. Services
4.5.1. Services, 2021 - 2033 (USD Million)
Chapter 5. DNA Sequencing Market: Technology Estimates & Trend Analysis
5.1. Technology Segment Dashboard
5.2. Global DNA Sequencing market: Technology Movement Analysis
5.3. Sanger sequencing
5.3.1. Sanger sequencing market estimates and forecasts 2021 to 2033, (USD Million)
5.4. Next-generation sequencing (NGS)
5.4.1. Next-generation sequencing (NGS), 2021 - 2033 (USD Million)
5.4.2. Whole genome sequencing (WGS)
5.4.2.1. Whole genome sequencing (WGS, 2021 - 2033 (USD Million)
5.4.3. Whole exome sequencing (WES)
5.4.3.1. Whole exome sequencing (WES), 2021 - 2033 (USD Million)
5.4.4. Targeted sequencing & resequencing
5.4.4.1. Targeted sequencing & resequencing, 2021 - 2033 (USD Million)
5.5. Third generation DNA sequencing
5.5.1. Third generation DNA sequencing, 2021 - 2033 (USD Million)
5.5.2. Single-molecule real-time sequencing (SMRT)
5.5.2.1. Single-molecule real-time sequencing (SMRT), 2021 - 2033 (USD Million)
5.5.3. Nanopore sequencing
5.5.3.1. Nanopore sequencing, 2021 - 2033 (USD Million)
Chapter 6. DNA Sequencing Market: Workflow Estimates & Trend Analysis
6.1. Workflow Segment Dashboard
6.2. Global DNA Sequencing market: Workflow Movement Analysis
6.3. Pre-sequencing
6.3.1. Pre-sequencing, 2021 - 2033 (USD Million)
6.4. Sequencing
6.4.1. Sequencing, 2021 - 2033 (USD Million)
6.5. Data Analysis
6.5.1. Data analysis, 2021 - 2033 (USD Million)
Chapter 7. DNA Sequencing Market: Application Estimates & Trend Analysis
7.1. Application Segment Dashboard
7.2. Global DNA Sequencing market: Application Movement Analysis
7.3. Oncology
7.3.1. Oncology, 2021 - 2033 (USD Million)
7.4. Reproductive Health
7.4.1. Reproductive health, 2021 - 2033 (USD Million)
7.5. Clinical Investigation
7.5.1. Clinical investigation, 2021 - 2033 (USD Million)
7.6. Agrigenomics & Forensics
7.6.1. Agrigenomics & forensics, 2021 - 2033 (USD Million)
7.7. HLA Typing/Immune System Monitoring
7.7.1. HLA Typing/Immune System Monitoring, 2021 - 2033 (USD Million)
7.8. Metagenomics, Epidemiology, & Drug Development
7.8.1. Metagenomics, epidemiology, & drug, 2021 - 2033 (USD Million)
7.9. Consumer Genomics
7.9.1. Consumer genomics, 2021 - 2033 (USD Million)
7.10. Others
7.10.1. Others, 2021 - 2033 (USD Million)
Chapter 8. DNA Sequencing Market: End-use Estimates & Trend Analysis
8.1. End-use Segment Dashboard
8.2. Global DNA Sequencing Market: End-use Movement Analysis
8.3. Academic Research
8.3.1. Academic research, 2021 - 2033 (USD Million)
8.4. Clinical Research
8.4.1. Clinical research, 2021 - 2033 (USD Million)
8.5. Hospitals & Clinics
8.5.1. Hospitals & clinics, 2021 - 2033 (USD Million)
8.6. Pharmaceutical & Biotechnology Companies
8.6.1. Pharmaceutical & biotechnology companies, 2021 - 2033 (USD Million)
8.7. Others
8.7.1. Others, 2021 - 2033 (USD Million)
Chapter 9. Regional Business Analysis
9.1. Global DNA sequencings market Share By Region, 2024 & 2033
9.2. North America
9.2.1. North America DNA sequencings market, 2021 - 2033 (USD Million)
9.2.2. U.S.
9.2.2.1. Key Country Dynamics
9.2.2.2. Competitive Scenario
9.2.2.3. Regulatory Framework
9.2.2.4. U.S. DNA sequencings market, 2021 - 2033 (USD Million)
9.2.3. Canada
9.2.3.1. Key Country Dynamics
9.2.3.2. Competitive Scenario
9.2.3.3. Regulatory Framework
9.2.3.4. Canada DNA sequencings market, 2021 - 2033 (USD Million)
9.2.4. Mexico
9.2.4.1. Key Country Dynamics
9.2.4.2. Competitive Scenario
9.2.4.3. Regulatory Framework
9.2.4.4. Mexico DNA sequencings market, 2021 - 2033 (USD Million)
9.3. Europe
9.3.1. Europe DNA sequencings market, 2021 - 2033 (USD Million)
9.3.2. Germany
9.3.2.1. Key Country Dynamics
9.3.2.2. Competitive Scenario
9.3.2.3. Regulatory Framework
9.3.2.4. Germany DNA sequencings market, 2021 - 2033 (USD Million)
9.3.3. UK
9.3.3.1. Key Country Dynamics
9.3.3.2. Competitive Scenario
9.3.3.3. Regulatory Framework
9.3.3.4. UK DNA sequencings market, 2021 - 2033 (USD Million)
9.3.4. France
9.3.4.1. Key Country Dynamics
9.3.4.2. Competitive Scenario
9.3.4.3. Regulatory Framework
9.3.4.4. France DNA sequencings market, 2021 - 2033 (USD Million)
9.3.5. Italy
9.3.5.1. Key Country Dynamics
9.3.5.2. Competitive Scenario
9.3.5.3. Regulatory Framework
9.3.5.4. Italy DNA sequencings market, 2021 - 2033 (USD Million)
9.3.6. Spain
9.3.6.1. Key Country Dynamics
9.3.6.2. Competitive Scenario
9.3.6.3. Regulatory Framework
9.3.6.4. Spain DNA sequencings market, 2021 - 2033 (USD Million)
9.3.7. Denmark
9.3.7.1. Key Country Dynamics
9.3.7.2. Competitive Scenario
9.3.7.3. Regulatory Framework
9.3.7.4. Denmark DNA sequencings market, 2021 - 2033 (USD Million)
9.3.8. Sweden
9.3.8.1. Key Country Dynamics
9.3.8.2. Competitive Scenario
9.3.8.3. Regulatory Framework
9.3.8.4. Sweden DNA sequencings market, 2021 - 2033 (USD Million)
9.3.9. Norway
9.3.9.1. Key Country Dynamics
9.3.9.2. Competitive Scenario
9.3.9.3. Regulatory Framework
9.3.9.4. Norway DNA sequencings market, 2021 - 2033 (USD Million)
9.4. Asia Pacific
9.4.1. Asia Pacific DNA sequencings market, 2021 - 2033 (USD Million)
9.4.2. Japan
9.4.2.1. Key Country Dynamics
9.4.2.2. Competitive Scenario
9.4.2.3. Regulatory Framework
9.4.2.4. Japan DNA sequencings market, 2021 - 2033 (USD Million)
9.4.3. China
9.4.3.1. Key Country Dynamics
9.4.3.2. Competitive Scenario
9.4.3.3. Regulatory Framework
9.4.3.4. China DNA sequencings market, 2021 - 2033 (USD Million)
9.4.4. India
9.4.4.1. Key Country Dynamics
9.4.4.2. Competitive Scenario
9.4.4.3. Regulatory Framework
9.4.4.4. India DNA sequencings market, 2021 - 2033 (USD Million)
9.4.5. South Korea
9.4.5.1. Key Country Dynamics
9.4.5.2. Competitive Scenario
9.4.5.3. Regulatory Framework
9.4.5.4. South Korea DNA sequencings market, 2021 - 2033 (USD Million)
9.4.6. Australia
9.4.6.1. Key Country Dynamics
9.4.6.2. Competitive Scenario
9.4.6.3. Regulatory Framework
9.4.6.4. Australia DNA sequencings market, 2021 - 2033 (USD Million)
9.4.7. Thailand
9.4.7.1. Key Country Dynamics
9.4.7.2. Competitive Scenario
9.4.7.3. Regulatory Framework
9.4.7.4. Thailand DNA sequencings market, 2021 - 2033 (USD Million)
9.5. Latin America
9.5.1. Latin America DNA sequencings market, 2021 - 2033 (USD Million)
9.5.2. Brazil
9.5.2.1. Key Country Dynamics
9.5.2.2. Competitive Scenario
9.5.2.3. Regulatory Framework
9.5.2.4. Brazil DNA sequencings market, 2021 - 2033 (USD Million)
9.5.3. Argentina
9.5.3.1. Key Country Dynamics
9.5.3.2. Competitive Scenario
9.5.3.3. Regulatory Framework
9.5.3.4. Argentina DNA sequencings market, 2021 - 2033 (USD Million)
9.6. MEA
9.6.1. MEA DNA sequencings market, 2021 - 2033 (USD Million)
9.6.2. South Africa
9.6.2.1. Key Country Dynamics
9.6.2.2. Competitive Scenario
9.6.2.3. Regulatory Framework
9.6.2.4. South Africa DNA sequencings market, 2021 - 2033 (USD Million)
9.6.3. Saudi Arabia
9.6.3.1. Key Country Dynamics
9.6.3.2. Competitive Scenario
9.6.3.3. Regulatory Framework
9.6.3.4. Saudi Arabia DNA sequencings market, 2021 - 2033 (USD Million)
9.6.4. UAE
9.6.4.1. Key Country Dynamics
9.6.4.2. Competitive Scenario
9.6.4.3. Regulatory Framework
9.6.4.4. UAE DNA sequencings market, 2021 - 2033 (USD Million)
9.6.5. Kuwait
9.6.5.1. Key Country Dynamics
9.6.5.2. Competitive Scenario
9.6.5.3. Regulatory Framework
9.6.5.4. Kuwait DNA sequencings market, 2021 - 2033 (USD Million)
Chapter 10. Competitive Landscape
10.1. Company Categorization
10.2. Strategy Mapping
10.3. Company Position Analysis, 2024
10.4. Company Profiles/Listing
10.4.1. Thermo Fisher Scientific, Inc
10.4.1.1. Company overview
10.4.1.2. Financial performance
10.4.1.3. Product & service benchmarking
10.4.1.4. Strategic initiatives
10.4.2. Agilent Technology
10.4.2.1. Company overview
10.4.2.2. Financial performance
10.4.2.3. Product & service benchmarking
10.4.2.4. Strategic initiatives
10.4.3. Illumina, Inc.
10.4.3.1. Company overview
10.4.3.2. Financial performance
10.4.3.3. Product & service benchmarking
10.4.3.4. Strategic initiatives
10.4.4. QIAGEN
10.4.4.1. Company overview
10.4.4.2. Financial performance
10.4.4.3. Product & service benchmarking
10.4.4.4. Strategic initiatives
10.4.5. F. Hoffmann-La Roche Ltd.
10.4.5.1. Company overview
10.4.5.2. Financial performance
10.4.5.3. Product & service benchmarking
10.4.5.4. Strategic initiatives
10.4.6. Macrogen, Inc.
10.4.6.1. Company overview
10.4.6.2. Financial performance
10.4.6.3. Product & service benchmarking
10.4.6.4. Strategic initiatives
10.4.7. PerkinElmer Genomics
10.4.7.1. Company overview
10.4.7.2. Financial performance
10.4.7.3. Product & service benchmarking
10.4.7.4. Strategic initiatives
10.4.8. PacBio
10.4.8.1. Company overview
10.4.8.2. Financial performance
10.4.8.3. Product & service benchmarking
10.4.8.4. Strategic initiatives
10.4.9. BGI
10.4.9.1. Company overview
10.4.9.2. Financial performance
10.4.9.3. Product & service benchmarking
10.4.9.4. Strategic initiatives
10.4.10. Bio-Rad Laboratories, Inc.
10.4.10.1. Company overview
10.4.10.2. Financial performance
10.4.10.3. Product & service benchmarking
10.4.10.4. Strategic initiatives
10.4.11. Myriad Genetics
10.4.11.1. Company overview
10.4.11.2. Financial performance
10.4.11.3. Product & service benchmarking
10.4.11.4. Strategic initiatives
10.4.12. PierianDx
10.4.12.1. Company overview
10.4.12.2. Financial performance
10.4.12.3. Product & service benchmarking
10.4.12.4. Strategic initiatives
10.4.13. Partek Incorporated
10.4.13.1. Company overview
10.4.13.2. Financial performance
10.4.13.3. Product & service benchmarking
10.4.13.4. Strategic initiatives
10.4.14. Eurofins Scientific
10.4.14.1. Company overview
10.4.14.2. Financial performance
10.4.14.3. Product & service benchmarking
10.4.14.4. Strategic initiatives

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us